Reading Disability
0
Pipeline Programs
1
Companies
3
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
Human BioSciencesWV - Martinsburg
3 programsGraphoLearn reading interventionN/A1 trial
Reading TutoringN/A1 trial
preKN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Human BioSciencesGraphoLearn reading intervention
Human BioSciencesReading Tutoring
Human BioSciencespreK
Clinical Trials (3)
Total enrollment: 754 patients across 3 trials
Neurocognitive Factors in EdTech Intervention Response
Start: Nov 2020Est. completion: Aug 2026450 patients
N/AActive Not Recruiting
Executive Function in Early Childhood
Start: Aug 2019Est. completion: Jul 2026260 patients
N/ARecruiting
University of Washington Reading & Dyslexia Research Program
Start: May 2019Est. completion: Jun 202144 patients
N/AUnknown
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 754 patients
1 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.